Shanghai Mokai Pharmaceutical Co., Ltd.

Technology development, technology transfer, technical consulting, technical services in the field of pharmaceutical intermediate technology, pharmaceutical consulting (not allowed to engage in diagnosis and treatment activities), investment management, computer services (except Internet access service business premises), Class I medical equipment, chemical raw materials and Sales of products (except hazardous chemicals, monitoring chemicals, fireworks, civilian explosives, and precursor chemicals), electronic products, electromechanical equipment, and cosmetics. [Projects that require approval according to law can only be carried out with approval from relevant departments]
Business Type Manufacturer
Location ChinaShanghaiJiading
Year Established 2012-04-05
Total Employees 0
Total Annual Revenue -
Main Products 1,3-benzothiadiazole, 2,1,3-benzothiadiazole, 3,4,5-trihydroxybenzoic acid, D4, propyl ester, sodium propionate, rivaroxaban, kason, Thiazide, enrofloxacin, modified starch, ganciclovir, chloramphenicol, propyl gallate, levamisole hydrochloride, sulfamethazine, sulfadiazine, hydroxyethyl starch, tartaric acid, ester, chlortetracycline
Main Market -